Cadila Healthcare inform about outcome of board meeting

09 Jul 2021 Evaluate

Cadila Healthcare has informed that Ganesh N. Nayak (DIN00017481) was appointed as the Whole Time Director and Chief Operating Officer of the Company for a period of 1 year with effect from July 12, 2020 and his term will expire on July 11, 2021. The Board of Directors at their meeting held today July 9, 2021, based on the recommendation of the Nomination and Remuneration Committee, approved re-appointment of Ganesh N. Nayak, as the Executive Director of the Company for a period of 3 years with effect from July 12, 2021. He shall be liable to retire by rotation. The said re-appointment shall be subject to approval of the shareholders at the ensuing Annual General Meeting by way of an Ordinary Resolution. Ganesh N. Nayak is not related to any of the Directors of the Company. He is not debarred from holding the office of director pursuant to any SEBI Order or any other authority. Brief profile of Ganesh N. Nayak is enclosed.

The above information is a part of company’s filings submitted to BSE.

Zydus Lifesciences Share Price

884.65 -11.95 (-1.33%)
29-Jan-2026 09:41 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1595.00
Dr. Reddys Lab 1199.20
Cipla 1311.90
Zydus Lifesciences 884.65
Lupin 2104.90
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×